Search Videos by Topic or Participant
Browse by Series:

Moving Away From Traditional Payment Models in Oncology

Panelists:Michael Kolodziej, MD, Aetna; Andrew L. Pecora, MD, FACP, CPE, John Theurer Cancer Center; Jeffery C. Ward, MD, Swedish Cancer Institute
Published: Thursday, Aug 27, 2015

 
The “buy and bill” reimbursement model has dominated oncology practice for many years. However, this system is problematic, since it creates the impression that there is a conflict of interest, notes Michael Kolodziej, MD. Under this model an oncology practice can make more money by treating less complicated cancers, since certain drugs have greater profit margins, adds Kolodziej.

The current reimbursement model will need to change, and the concept of incentivizing quality is good in theory, notes Kolodziej. However, the solution is far more complicated than just replacing the "buy and bill" model with one based on outcomes.
 
Fee-for-service has similar disincentives, according to Jeffrey C. Ward, MD. The clinics are able to bill for infusions and patient visits, but reimbursement is lacking for nutrition consultations, social worker consultations, financial counseling, and patient education. Oncology clinics can offer these additional services in part because of the profit they receive through buy-and-bill, adds Ward.
 
Slider Left
Slider Right

 
The “buy and bill” reimbursement model has dominated oncology practice for many years. However, this system is problematic, since it creates the impression that there is a conflict of interest, notes Michael Kolodziej, MD. Under this model an oncology practice can make more money by treating less complicated cancers, since certain drugs have greater profit margins, adds Kolodziej.

The current reimbursement model will need to change, and the concept of incentivizing quality is good in theory, notes Kolodziej. However, the solution is far more complicated than just replacing the "buy and bill" model with one based on outcomes.
 
Fee-for-service has similar disincentives, according to Jeffrey C. Ward, MD. The clinics are able to bill for infusions and patient visits, but reimbursement is lacking for nutrition consultations, social worker consultations, financial counseling, and patient education. Oncology clinics can offer these additional services in part because of the profit they receive through buy-and-bill, adds Ward.
 
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x